The Basser Center for BRCA is the first comprehensive center for the research, treatment, and prevention of BRCA-related cancers. These hereditary mutations affect both men and women and can be passed down from either parent. BRCA mutations can increase lifetime risk for cancers including breast, ovarian, pancreatic, prostate and melanoma. The Basser Center can help you learn more about hereditary cancer risk. Make an appointment with us or locate a genetic counselor in your area. Watch this Pierce Brosnan narrated video to learn more about BRCA and Basser’s progress towards a cure.

Knowledge is Power: Understanding and Managing BRCA-Related Cancer Risk

The Basser Center for BRCA and the Lawrence Family Jewish Community Center presented Knowledge is Power: Understanding and Managing BRCA-Related Cancer Risk, a dynamic evening in July 2018 about the experience of living with BRCA mutations and hereditary cancers. As these mutations affect all populations, a panel of experts in the field discussed genetic counseling and testing, preventive care and navigating through the challenging decision-making and medical management options faced by mutation carriers. Panelists included Dr. Susan Domchek, Basser Center Executive Director, Dr. Paul Hyde, Scripps Hospital breast and general surgeon, Dr. David Smotrich, La Jolla IVF Medical Director, Dr. Lisa Madlensky, Moores UCSD Genetics Program Director, and Sarah Abelsohn, a community member impacted by these issues. The panel was moderated by journalist Jill Werman Harris. Read more about the event at the La Jolla Light.

Celebrating 5 Years of Progress and Hope

The latest Basser Center progress report report highlights the Center’s considerable impact in advancing promising discoveries, fostering national and international research collaborations, and enabling FDA approvals for PARP inhibitors. Equally significant is the work the Center does every day to underscore the importance of knowing one’s family history, and to thoughtfully guide individuals and families faced with a BRCA gene mutation. Read the 2017 Progress Report now.

2017 Progress Report

What’s My Cancer Risk?

 Woman sitting at table looking at photographs
Genetic counseling

Learn about cancer risk evaluation, hereditary links between cancers, BRCA-related cancer risks and inheritance, and the genetic counseling process.

Managing and reducing your cancer risk

Find information on BRCA risk management and screening. Learn about surgical and medical options for decreasing risk and the reproductive effects seen in BRCA mutation carriers.

Insurance

Find commonly asked questions about the cost and coverage of genetic testing and cancer screenings, as well as the impact of genetic test results on health and life insurance.

Support and resources

Get your questions answered and find resources to help cope with news of a BRCA mutation or cancer, as well as tips on communicating with family members about risks, care and support.

INCREASED LIFETIME CANCER RISK

WITH A BRCA MUTATION

BREAST

%

UP
TO

OVARIAN

%

UP
TO

PROSTATE

%

UP
TO

Creating Better Choices
for Future Generations

Our team science approach seeks a cure by advancing the care for BRCA-related cancers.

Learn more about the groundbreaking studies funded by the Basser Center.

The Basser Center for BRCA provides grant funding to investigators around the world working on innovative projects related to BRCA1 and BRCA2.

Basser Global Prize

The Basser Global Prize provides $100,000 in unrestricted support of the awardee's innovative BRCA1/2 related research efforts.

Managing your cancer risk
Find a genetic counselor
Ways to Give

Philanthropy helps to provide essential resources supporting the Center’s mission to improve the lives of individuals with BRCA1 and BRCA2 mutations.

Upcoming Events

Learn more about our latest events raising awareness of BRCA-related cancers and revisit some of our past programs.

Basser T-shirt
Basser Gear

Help us fuel research through fashion by shopping in the Basser store, where we have branded T-shirts and jean jackets.